• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLTA MEDICAL INC. THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLTA MEDICAL INC. THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC. Back to Search Results
Model Number TT4.00F6-900
Device Problems Improper or Incorrect Procedure or Method (2017); Insufficient Information (3190)
Patient Problems Erythema (1840); Partial thickness (Second Degree) Burn (2694)
Event Date 12/16/2019
Event Type  Injury  
Manufacturer Narrative
The first treatment tip was discarded and is not available for evaluation.Product evaluation was completed on the second treatment tip.Tip passed leak, visual, and thermistor testing.No functional testing was performed because the tip was expired.System data-log was reviewed, both the system and hand-piece performed as expected.A review of the device history record is in progress.Based on all available information, no causal factors can be determined and no conclusion can be drawn.
 
Event Description
It was reported by a physician's office that a patient experienced a burn following a thermage treatment.The patient was treated across the face and neck with a maximum power level of 7.The doctor reported that the patient was administered iv pain medication during the treatment.Following the procedure the patient returned home and then noticed that they had a second degree burn on both cheeks and neck.They visited a dermatology clinic and received an unknown treatment.The doctor indicated that cryogen coupling fluid was administered properly, and that the surfaces of both treatment tips were inspected prior to and during use with no observed abnormalities.After 325 pulses the first treatment tip was displaying an ec78c ''tip too warm'' error and was discarded for a second treatment tip.The treatment was completed with the second tip without any additional errors or issues.
 
Manufacturer Narrative
A review of the manufacturing records showed all requirements were met; the lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.Data-logs confirmed the system and hand-piece perform as expected.Evaluation of the treatment tip found no issues.It was reported the patient was placed under sleep anesthesia.The patient should never be placed under anesthetics during thermage flx treatment.The customer must be alert and provide required feedback during treatment.Patient feedback regarding their perception of heat or discomfort during the procedure is an essential input to guide the operator in determining safe and effective treatment levels.Based on the available information, this treatment was performed in an off-label manner that resulted in unsafe conditions for the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES
Type of Device
ELECTROSURGICAL,CUTTING & COAGULATION & ACC.
Manufacturer (Section D)
SOLTA MEDICAL INC.
11720 north creek pkwy n
suite 100
bothell WA 98011
MDR Report Key9603991
MDR Text Key176767837
Report Number3011423170-2020-00009
Device Sequence Number1
Product Code GEI
Combination Product (y/n)Y
PMA/PMN Number
K170758
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/01/2005,12/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberTT4.00F6-900
Device Catalogue NumberTT4.00F6-900
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/09/2020
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received02/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age49 YR
-
-